Safety and effectiveness of high-dose vitamin C in patients with COVID-19: a randomized open-label clinical trial
Saeidreza Jamalimoghadamsiahkali, Besharat Zarezade, Sogol Koolaji, SeyedAhmad SeyedAlinaghi, Abolfazl Zendehdel, Mohammad Tabarestani +11 more
European journal of medical research
Abstract
We did not find significantly better outcomes in the group who were treated with HDIVC in addition to the main treatment regimen at discharge. Trial registration irct.ir (IRCT20200411047025N1), April 14, 2020.
Concepts
MedicineLopinavirRegimenRandomized controlled trialHydroxychloroquineCoronavirus disease 2019 (COVID-19)Internal medicineClinical trial